Table 3 The clinicopathologic characteristics of the patients
Clinicopathologic factors | Number of patients (%) |
|---|---|
Tumor grade | |
 1 | 12 (8.3) |
 2 | 81 (55.9) |
 3 | 52 (35.8) |
Nuclear grade | |
 Mild and moderate | 72 (49.7) |
 Marked | 73 (50.3) |
Mitosis | |
 0–9/10 HPFs | 32 (22.1) |
 10–24/10 HPFs | 61 (42.1) |
 ≥ 25/10 HPFs | 52 (35.8) |
Residual tumor | |
 Optimal | 93 (88.6) |
 Suboptimal | 12 (11.4) |
Tumor stage | |
 Early | 21 (20.0) |
 Advanced | 84 (80.0) |
Chemoresponse | |
 Regressive disease | 45 (46.4) |
 Stable/progressive disease | 52 (53.6) |
Stromal TILs | |
 Low stromal TIL group | 112 (77.2) |
 High stromal TIL group | 33 (22.8) |